Engineers Gate Manager LP Syndax Pharmaceuticals Inc Transaction History

Engineers Gate Manager LP

$5.55 Billion
Q1 2025

A detailed history of Engineers Gate Manager LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 126,485 shares of SNDX stock, worth $1.12 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

126,485

Previous 147,673 14.35%

Holding current value

$1.12 Million

Previous $1.95 Million 20.39%

% of portfolio

0.03%

Previous 0.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$12.29 - $16.38 $260,400 - $347,059	-21,188 Reduced 14.35%	126,485 $1.55 Million
Q4 2024 Feb 14, 2025	BUY	$12.52 - $21.81 $1.11 Million - $1.92 Million	88,262 Added 148.56%	147,673 $1.95 Million
Q3 2024 Nov 14, 2024	SELL	$17.93 - $24.81 $294,571 - $407,603	-16,429 Reduced 21.66%	59,411 $1.14 Million
Q2 2024 Aug 14, 2024	BUY	$18.82 - $23.79 $627,703 - $793,467	33,353 Added 78.5%	75,840 $1.56 Million
Q1 2024 May 15, 2024	BUY	$19.71 - $24.57 $517,328 - $644,888	26,247 Added 161.62%	42,487 $1.01 Million
Q4 2023 Feb 14, 2024	SELL	$11.39 - $21.67 $618,431 - $1.18 Million	-54,296 Reduced 76.98%	16,240 $350,000
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $142,194 - $213,193	9,793 Added 16.12%	70,536 $1.02 Million
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $180,303 - $207,884	9,318 Added 18.12%	60,743 $1.27 Million
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $1.06 Million - $1.49 Million	51,425 New	51,425 $1.09 Million
Q2 2022 Aug 15, 2022	SELL	$13.64 - $19.48 $556,566 - $794,861	-40,804 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $259,789 - $387,757	17,506 Added 75.14%	40,804 $709,000
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $354,828 - $523,506	23,298 New	23,298 $510,000
Q3 2021 Nov 15, 2021	SELL	$13.87 - $19.8 $230,366 - $328,858	-16,609 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$13.42 - $25.18 $90,705 - $170,191	-6,759 Reduced 28.92%	16,609 $285,000
Q1 2021 May 17, 2021	BUY	$19.28 - $24.59 $107,042 - $136,523	5,552 Added 31.16%	23,368 $523,000
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $269,021 - $471,055	17,816 New	17,816 $396,000

Others Institutions Holding SNDX

# of Institutions

240

Shares Held

101M

Call Options Held

1.36M

Put Options Held

618K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $499M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Syndax Pharmaceuticals Inc Transaction History